glp-1 ibd 🚨 RA use in is rising fast In this 14-month repeated survey of patients with IBD: 📈 GLP-1 RA use rose 5-fold ⚖️ Median BMI fell from 35.3 → 31.2 GLP-1 Receptor Agonists Reduce Colorectal

adults from May 28 to June 5, 2026 and first asked respondents whether theyve ever taken weight loss medications like semaglutide (sold under brand names like Ozempic and Wegovy), liraglutide (prescribed under the name Saxenda) or tirzepatide (brand names Mounjaro and Zepbound)

She earned her Master of Science in Nursing from Saint Josephs College of Maine and has over five years experience in healthcare

When will Eli Lilly's oral obesity pill be approved

Microbiol 40 , 852856 (2002)

In vitro signaling studies demonstrated that tirzepatide was able to activate the GIP receptor with comparable potency to native GIP (57)